Fund Holdings — Pennant Investors, LP

Total Portfolio Value
$335.97M
Total Bought
$61.32M
Total Sold
$97.24M
Net Transaction
-$35.92M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ECHOSTAR CORP(ECHO)2,153,2092,320,837+167,62838,34957,60317.15%+19,255
PERIMETER SOLUTIONS SA(PRM)2,300,0002,700,000+400,00018,00936,31510.81%+18,306
VERTIV HOLDINGS CO(VRT)115,000160,000+45,0009,95615,9184.74%+5,963
ASML HOLDING N V
N Y REGISTRY SHS
06,500+6,50005,4161.61%+5,416
GE VERNOVA INC(GEV)60,00060,000010,29115,2994.55%+5,008
ANTERO RESOURCES CORP(AR)836,0001,126,000+290,00027,27932,2609.60%+4,981
CORE SCIENTIFIC INC NEW(CORZ)500,000794,813+294,8134,6509,4262.81%+4,776
IRIS ENERGY LTD
ORDINARY SHARES
470,000940,000+470,0005,3067,9342.36%+2,627
VALMONT INDS INC(VMI)40,00040,000010,97811,5983.45%+620
GRAB HOLDINGS LIMITED
*W EXP 99/99/999
80,00080,000013190.01%+6
BLUEBIRD BIO INC87,4000-87,400860—-86
BIOXCEL THERAPEUTICS INC(BTAI)83,9000-83,9001070—-107
ZENTALIS PHARMACEUTICALS INC(ZNTL)32,4000-32,4001330—-133
ALLOVIR INC215,7000-215,7001560—-156
ALLAKOS INC186,1000-186,1001860—-186
MACROGENICS INC(MGNX)43,8000-43,8001860—-186
GETAROUND INC1,348,1530-1,348,1531890—-189
SAGE THERAPEUTICS INC17,5000-17,5001900—-190
COMPASS THERAPEUTICS INC(CMPX)199,0000-199,0001990—-199
SERES THERAPEUTICS INC(MCRB)292,3000-292,3002120—-212
UNIQURE NV(QURE)48,5000-48,5002170—-217
REPLIMUNE GROUP INC(REPL)30,5000-30,5002750—-274
RELAY THERAPEUTICS INC(RLAY)42,4000-42,4002760—-276
COHERUS BIOSCIENCES INC(CHRS)168,1000-168,1002910—-291
ALLOGENE THERAPEUTICS INC128,4000-128,4002990—-299
ARCTURUS THERAPEUTICS HLDGS(ARCT)13,1000-13,1003190—-319
ZYMEWORKS INC(ZYME)38,7000-38,7003290—-329
89BIO INC44,5000-44,5003560—-356
ARCUS BIOSCIENCES INC(RCUS)23,7000-23,7003610—-361
ERASCA INC(ERAS)166,2000-166,2003920—-392
IGM BIOSCIENCES INC64,9000-64,9004460—-446
ENANTA PHARMACEUTICALS INC(ENTA)35,1000-35,1004550—-455
TRAVERE THERAPEUTICS INC(TVTX)55,8000-55,8004590—-459
FATE THERAPEUTICS INC(FATE)146,1000-146,1004790—-479
AGIOS PHARMACEUTICALS INC(AGIO)15,1000-15,1006510—-651
FIBROGEN INC768,4000-768,4006860—-686
ALTIMMUNE INC(ALT)109,8000-109,8007300—-730
NOVAVAX INC(NVAX)60,3000-60,3007630—-763
NURIX THERAPEUTICS INC(NRIX)56,8000-56,8001,1850—-1,185
ARCUTIS BIOTHERAPEUTICS INC(ARQT)170,9000-170,9001,5890—-1,589
ALPHABET INC(GOOG)183,000153,000-30,00033,33325,3757.55%-7,958
AMAZON COM INC(AMZN)240,000182,000-58,00046,38033,91210.09%-12,468
TRANSDIGM GROUP INC(TDG)32,37119,371-13,00041,35827,6458.23%-13,713
MICROSOFT CORP(MSFT)80,00051,000-29,00035,75621,9456.53%-13,811
THE ODP CORP400,0000-400,00015,7080—-15,708
MICRON TECHNOLOGY INC(MU)431,000340,432-90,56856,68935,30610.51%-21,383
Page 1 of 1
Pennant Investors, LP — 13F Holdings — Q3 2024 | TickerTrail